Alexander C. Conley

ORCID: 0000-0003-1159-5524
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Estrogen and related hormone effects
  • Down syndrome and intellectual disability research
  • Menopause: Health Impacts and Treatments
  • Receptor Mechanisms and Signaling
  • Cholinesterase and Neurodegenerative Diseases
  • Transcranial Magnetic Stimulation Studies
  • EEG and Brain-Computer Interfaces
  • Cancer-related cognitive impairment studies
  • ECG Monitoring and Analysis
  • Motor Control and Adaptation
  • Obsessive-Compulsive Spectrum Disorders
  • Neural and Behavioral Psychology Studies
  • Muscle activation and electromyography studies
  • Eating Disorders and Behaviors
  • Dementia and Cognitive Impairment Research
  • Nicotinic Acetylcholine Receptors Study
  • Autism Spectrum Disorder Research
  • Tryptophan and brain disorders
  • Functional Brain Connectivity Studies
  • Treatment of Major Depression
  • Computational Drug Discovery Methods
  • Memory and Neural Mechanisms
  • Attention Deficit Hyperactivity Disorder
  • Alzheimer's disease research and treatments
  • Neural dynamics and brain function

Vanderbilt University Medical Center
2017-2025

Hunter Medical Research Institute
2015-2018

University of Newcastle Australia
2015-2018

Cognitive Neuroimaging Lab
2015-2017

Adults with Down syndrome are genetically predisposed to developing Alzheimer's disease after the age of 40. The cholinergic system, which is critical for cognitive functioning, known decline in and although first investigated individuals 40 years ago, remains relatively understudied. Existing studies suggest have an intact system at birth that declines through adulthood alongside development pathology. present study provides description terminals vivo non-demented adults utilizing...

10.1016/j.neurobiolaging.2025.01.008 article EN cc-by-nc-nd Neurobiology of Aging 2025-01-01

<title>Abstract</title> The development of cholinergic neurotransmitter based cognitive enhancers for Alzheimer’s disease and other neuropsychiatric disorders have focused recently on allosteric modulation specific muscarinic acetylcholine receptor (mAChR) subtypes to reduce dose-limiting side-effects that been the hallmark earlier orthosteric mAChR agonists. VU0467319 (VU319) is an investigational positive modulator M<sub>1</sub> mAChR. A Phase 1 first-in-human study was conducted assessing...

10.21203/rs.3.rs-6271510/v1 preprint EN Research Square (Research Square) 2025-04-04

Abstract BACKGROUND Adults with Down syndrome (DS) have increased risk of Alzheimer's disease (AD). The cholinergic system declines in AD, underlying many cognitive deficits. We investigated the relationship between amyloid accumulation and terminal density adults DS compared to amyloid‐matched controls. METHODS A total 15 non‐demented healthy controls were assessed for [ 18 F]‐FEOBV uptake differences relationships performance. RESULTS displayed greater than controls, a similar pattern....

10.1002/alz.70134 article EN cc-by Alzheimer s & Dementia 2025-04-01

Purpose: Research popularity and scope for the application of transcranial direct current stimulation have been steadily increasing yet many fundamental questions remain unanswered.We sought to determine if anodal either hemisphere leads improved performance contralateral hand and/or altered function ipsilateral hand, or affects movement preparation, in older subjects.Method: In this cross-over, double blind, sham controlled study, 34 healthy aged participants (age range 40-86) were...

10.3233/rnn-140490 article EN other-oa Restorative Neurology and Neuroscience 2015-08-19

Sensory over-responsivity (SOR) refers to excessively intense and/or prolonged behavioral responses environmental stimuli typically perceived as non-aversive. SOR is prevalent in several neurodevelopmental disorders, including chronic tic disorders (CTDs) and obsessive-compulsive disorder (OCD). Few studies have examined the extent clinical correlates of across limiting insights into phenomenon's transdiagnostic biological relevance. Such cross-disorder comparisons are particular interest...

10.1016/j.comppsych.2021.152291 article EN cc-by-nc-nd Comprehensive Psychiatry 2021-12-17

Late-life depression (LLD) is characterized by poor antidepressant response and cognitive dysfunction. This study examined whether transdermal nicotine benefits mood symptoms performance in LLD.

10.4088/jcp.18m12137 article EN The Journal of Clinical Psychiatry 2018-08-27

Sensory hypersensitivity, defined as heightened awareness of and reactivity to external stimuli, is a bothersome symptom that affects up 80% adults with Tourette syndrome (TS). Such widespread prevalence suggests sensory hypersensitivity core feature the disorder, but its severity association other clinical features TS remain largely unexplored. Complicating matters, has been observed in two neurodevelopmental disorders commonly comorbid TS: obsessive-compulsive disorder (OCD) attention...

10.2147/ndt.s274165 article EN cc-by-nc Neuropsychiatric Disease and Treatment 2020-11-01

Anodal transcranial direct current stimulation (tDCS) over the primary motor cortex (M1) has been proposed as a possible therapeutic rehabilitation technique for impairment. However, despite extensive investigation into effects of anodal tDCS on output, there is little information how affects response processes. In this study, we used cued go/nogo task with both directional and non-directional cues to assess dominant (left) prepared unprepared responses. Three experiments explored whether...

10.1371/journal.pone.0124509 article EN cc-by PLoS ONE 2015-05-01

Anodal transcranial direct current stimulation (tDCS) over the motor cortex is considered a potential treatment for rehabilitation following stroke and other neurological pathologies. However, both context under which this effective underlying mechanisms remain to be determined. In study, we examined by anodal tDCS may affect performance recording event-related potentials (ERPs) during cued go/nogo task after dominant M1 in young adults (Experiment 1) non-dominant old 2). experiments, had no...

10.3389/fnhum.2016.00384 article EN cc-by Frontiers in Human Neuroscience 2016-08-05

Abstract Adults with Down syndrome are genetically predisposed to developing Alzheimer’s disease after the age of 40. The cholinergic system, which is critical for cognitive functioning, known decline in and although first investigated individuals 40 years ago, remains relatively understudied. Existing studies suggest have an intact system at birth that declines through adulthood alongside development pathology. present study provides description terminals vivo non-demented adults utilizing...

10.1101/2024.10.28.24316136 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-11-01

Abstract Objective: Menopause is associated with increasing cognitive complaints and older women are at increased risk of developing Alzheimer disease compared to men. However, there difficulty in early markers using objective performance measures. We investigated the impact subjective on cortical structure a sample younger postmenopausal women. Methods: Data for this cross-sectional study were drawn from baseline visit longer double-blind examining estrogen-cholinergic interactions normal...

10.1097/gme.0000000000001613 article EN Menopause The Journal of The North American Menopause Society 2020-07-20

Event-related potential (ERP) studies using the task-switching paradigm show that multiple ERP components are modulated by activation of proactive control processes involved in preparing to repeat or switch task and reactive implementation current new task. Our understanding functional significance these has been hampered variability their robustness, as well temporal scalp distribution across studies. The aim this study is examine effect choice reference electrode spatial filter on number,...

10.3389/fnins.2018.00143 article EN cc-by Frontiers in Neuroscience 2018-03-08

Purpose Chemotherapy-related cognitive impairment (CRCI) is a distressing and increasingly recognized long-term sequela reported by breast cancer patients following treatment. There an urgent but unmet clinical need for treatments that improve CRCI. In this context, we proposed the use of novel enhancement strategy called Neuroflex to target CRCI experienced survivors. Methods The primary aim pilot study was evaluate feasibility acceptability Neuroflex, digital strategy, in gynecologic...

10.1177/20552076231192754 article EN cc-by-nc-nd Digital Health 2023-01-01

Aging is associated with increased prevalence of vascular health conditions. These are changes in the cardiac vasculature and detrimental to cerebral structure function, most strikingly white matter. Previous research has shown that arterial pulsatility related decreased matter microstructural organization impaired cognitive functioning. However, this relationship was only significant people cardiovascular risk factors. Conversely, absence factors thought relate better long-term health. This...

10.3389/fnagi.2020.00245 article EN cc-by Frontiers in Aging Neuroscience 2020-08-07

Abstract Background VU319 is an investigational positive allosteric modulator of the M 1 muscarinic acetylcholine receptor developed for cognitive enhancement in Alzheimer’s disease (AD) and other disorders. Cognitive tasks including test attention, speed, memory event‐related potentials (ERPs) were used during double‐blind, placebo controlled Single Ascending Dose (SAD) study VU319. The main pharmacodynamic objectives SAD to identify early markers functional engagement. Following ascending...

10.1002/alz.045339 article EN Alzheimer s & Dementia 2020-12-01

Transcranial direct current stimulation (tDCS) has been proposed as a tool to enhance stroke rehabilitation; however, evidence support its use is lacking. The aim of this study was investigate the effects anodal and cathodal tDCS on upper limb function in chronic patients. Twenty five participants were allocated receive 20 min 1 mA anodal, or sham cortical random, counterbalanced order. Patients assessors blinded intervention at each time point. primary outcome performance measured by Jebsen...

10.1097/mrr.0000000000000220 article EN International Journal of Rehabilitation Research 2017-02-14

Older women are at increased risk of developing Alzheimer's disease compared to men. One proposed reason is that following menopause there a decline in estrogens. Estrogens important for cholinergic functioning and attenuate the impact antagonists on cognitive performance postmenopausal women. Self-reported or subjective complaints middle older age may represent harbinger those who endorse appear more likely develop future impairment. However, response individuals with after estrogen...

10.1002/hup.2838 article EN Human Psychopharmacology Clinical and Experimental 2022-02-24

M1 is the primary muscarinic acetylcholine receptor (mAChR) subtype involved in domains of cognitive function impaired Alzheimer's disease. Previous orthosteric and allosteric agonists developed to activate mAChRs have failed clinical development due a lack true specificity for resulting dose-limiting adverse effects. We focused on modulation less highly conserved binding sites avoid these difficulties. Our investigational lead (VU319) has robust M1-mediated effects hippocampal synaptic...

10.1016/j.jalz.2019.06.1231 article EN Alzheimer s & Dementia 2019-07-01

Introduction Women are at a higher risk of developing Alzheimer’s disease (AD), and the decline in estrogens post-menopause is thought as factor increasing this risk. Estradiol (E2) important supporting cholinergic neuronal integrity, functioning may be negatively impacted following loss E2 post-menopause. The use exogenous has been observed to enhance cholinergically mediated cognitive performance healthy post-menopausal women, which indicates potentially protective mechanism. However,...

10.3389/fnins.2024.1428675 article EN cc-by Frontiers in Neuroscience 2024-08-08
Coming Soon ...